Mark William Lowdell - 27 Oct 2021 Form 4 Insider Report for Inmune Bio, Inc. (INMB)

Role
Chief Scientific Officer, 10%+ Owner
Signature
/s/ Mark William Lowdell
Issuer symbol
INMB
Transactions as of
27 Oct 2021
Net transactions value
-$47,140
Form type
4
Filing time
29 Oct 2021, 16:03:35 UTC
Previous filing
26 Oct 2021
Next filing
04 Nov 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction INMB Common Stock Sale $47,140 -2,357 -0.16% $20.00 1,473,494 27 Oct 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.